Crossover Funds 2026: Why Fidelity and T. Rowe Price Cut Deal Volume 67%

Crossover funds now average roughly 170 private tech deals per quarter in 2026 — about a third of 2021's ~510-deal pace. That's the short answer. The longer answer is more interesting.

Fidelity, T. Rowe Price, and their peers didn't leave venture capital. They got a lot more selective about where the checks go — and the checks that remain are enormous.

What happened to crossover funds venture capital in 2026

Crossover funds — mutual funds, hedge funds, and asset managers that normally trade public equities but allocate a slice of capital to private, pre-IPO companies — cut deal frequency by roughly two-thirds between 2021 and 2026 while their dollar footprint barely moved. PitchBook data shows these investors averaging around 170 deals per quarter over the last 10 quarters, down from roughly 510 a quarter at the 2021 peak. But crossover-backed deals still represented 42% of total 2024 US venture dollar volume despite being just 4.9% of total deal count.

That combination — far fewer deals, still-massive dollars — is the entire story. Crossover capital didn't retreat from venture. It concentrated into a small number of mega-rounds for companies with a visible, near-term path to an IPO, and walked away from the mid-size growth rounds it used to fund by the dozen.

Why Fidelity and T. Rowe Price pulled back on deal volume

The 2022–2023 correction left a scar. Mutual funds are required to mark private holdings to fair value on a regular cadence, and when public comparables cratered, roughly 70% of the venture-backed positions held by funds like Fidelity and T. Rowe Price got written down, by an average of 35% and in some cases by as much as 85% from their peak marks. That forced discipline that early-stage VCs, who only report at fund close or on their own schedule, never had to face in public.

Where crossover fund venture capital dollars actually went in 2026

Databricks is the clearest case study. The company raised $4B in December 2025 at a $134B valuation — more than double its $62B mark from the start of 2025 — in a round led by Insight Partners, Fidelity, and J.P. Morgan Asset Management, with BlackRock, Blackstone, T. Rowe Price, Tiger Global, Thrive Capital, and Robinhood Ventures all participating. By June 2026, Databricks was reportedly in talks for a follow-on round at $165–175B. Meanwhile, SpaceX priced its June 2026 IPO at $135/share ($1.77 trillion valuation), popped 11% on debut, closed its books on $85.7B in gross proceeds — the largest US IPO on record — and reached a post-IPO valuation of roughly $2.3 trillion. Anthropic, which filed confidentially for an IPO on June 1, 2026 at a $965B valuation after a $65B Series H, is the next name in the same cohort.

Figures are 2025–2026 estimates blended from TechCrunch, CNBC, Tracxn, and company/press disclosures. Valuations for pending or in-talks rounds reflect reported terms as of June 2026 and may change before close.

Crossover fund deal count vs. dollar share, 2021–2026

The chart below is the whole thesis in one picture: deal count has collapsed while dollar concentration has held near record highs.

Which mega-rounds have crossover investors in 2026

A handful of category leaders are absorbing nearly all the crossover capital left in the system. This is where the dollars are, not where the deal count is.

What the crossover fund pullback means for startups raising in 2026

For most founders raising a Series B or C in 2026, the practical read is simple: don't plan your round around a crossover check unless you're already a category leader with a credible near-term IPO story. Track the broader fundraising climate on the VC Fund Performance Dashboard and the live IPO pipeline on the Tech IPO Tracker at Value Add VC.